Literature DB >> 36117927

Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c.

Shunsuke Kato1, Izumi Otaka1, Hanako Toyama1, Ryota Kusumi1, Kazuyuki Takahashi1, Mitsuhiko Nara1, Yumi Suganuma1, Takehiro Sato1, Tsukasa Morii1, Hiroki Fujita1, Hironori Waki1.   

Abstract

Although the measurement of hemoglobin A1c (HbA1c) using high-performance liquid chromatography (HPLC) is routinely used to estimate average blood glucose levels, it may not be accurately measured for various reasons, such as alteration of red blood cell lifespan and the existence of hemoglobin variants; including hemoglobin F (HbF). Here, we report cases of fulminant type 1 and type 2 diabetes mellitus in which HbA1c levels were unmeasurable because of increased labile HbA1c levels. Case 1 involved a 73-year-old man with fulminant type 1 diabetes mellitus, who was brought to our hospital with diabetic ketoacidosis. The patient's blood glucose level was 994 mg/dL, and HbA1c was unmeasurable, which turned out to be 6.2% on the next day when the blood glucose level was normalized. Case 2 involved a 72-year-old man with type 2 diabetes mellitus, whose blood glucose level was 767 mg/dL, and HbA1c was unmeasurable, which turned out to be 17.9% the following day. In both cases, the chromatograms showed that the HbA1c peaks overlapped with large labile HbA1c peaks, which decreased the next day. It is important to keep in mind that HbA1c levels may not be accurately measured in cases of extreme hyperglycemia because of an increase in labile HbA1c, regardless of the absolute HbA1c level. © The Japan Diabetes Society 2022.

Entities:  

Keywords:  Fulminant type 1 diabetes; HPLC; Hyperglycemia; Labile HbA1c; Type 2 diabetes

Year:  2022        PMID: 36117927      PMCID: PMC9477998          DOI: 10.1007/s13340-022-00593-y

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  24 in total

Review 1.  Tests of glycemia in diabetes.

Authors:  David E Goldstein; Randie R Little; Rodney A Lorenz; John I Malone; David Nathan; Charles M Peterson; David B Sacks
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

2.  Assessing agreement between the three common clinical measurement methods of HbA1c.

Authors:  Mohammad Taha Jalali; Samaneh Salehipour Bavarsad; Saeed Hesam; Mohammad Reza Afsharmanesh; Narges Mohammadtaghvaei
Journal:  J Diabetes Metab Disord       Date:  2020-02-11

3.  A Rare Case of Variant Hemoglobin (Hb Yahata) Suspected Based on Inconsistent Plasma Glucose and HbA1c Levels.

Authors:  Katsumi Iizuka; Masami Mizuno; Hiroyuki Niwa; Jun Takeda
Journal:  Intern Med       Date:  2015-07-15       Impact factor: 1.271

Review 4.  A review of variant hemoglobins interfering with hemoglobin A1c measurement.

Authors:  Randie R Little; William L Roberts
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

5.  Effect of Schiff base (labile fraction) on the measurement of glycated hemoglobin by affinity chromatography.

Authors:  W G John
Journal:  Clin Chem       Date:  1984-06       Impact factor: 8.327

6.  The effect of blood glucose concentration on labile A1c in diabetic patients.

Authors:  R Kawahara; T Amemiya; T Komori; Y Hirata
Journal:  Diabetes Care       Date:  1985 Jul-Aug       Impact factor: 19.112

7.  Evaluation of glycosylated hemoglobin diabetic patients.

Authors:  H F Bunn
Journal:  Diabetes       Date:  1981-07       Impact factor: 9.461

8.  HbA1c levels measured by enzymatic assay during off-site health checkups are lower than those measured by on-site HPLC assay.

Authors:  Masafumi Koga; Mari Okuda; Shinya Inada; Shin-Ichiro Ueda; Yuko Nakamura; Toshika Okumiya; Midori Ishibashi
Journal:  Diabetol Int       Date:  2019-08-27

9.  Labile glycated hemoglobin: an underestimated laboratory marker of short term glycemia.

Authors:  Joris R Delanghe; Stijn Lambrecht; Tom Fiers; Marijn M Speeckaert
Journal:  Clin Chem Lab Med       Date:  2022-01-19       Impact factor: 3.694

10.  A case of α-chain variant hemoglobin (Hb Chad) with falsely high HbA1c levels measured by immunoassay.

Authors:  Kei Yoshino; Yushi Hirota; Wataru Ogawa; Kenji Sugawara; Akira Kawaguchi; Hiroshi Yoshino; Midori Ishibashi; Gen Yoshino; Masafumi Koga
Journal:  Diabetol Int       Date:  2021-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.